International GAAP® 2019: Generally Accepted Accounting Practice under International Financial Reporting Standards

Home > Other > International GAAP® 2019: Generally Accepted Accounting Practice under International Financial Reporting Standards > Page 705
International GAAP® 2019: Generally Accepted Accounting Practice under International Financial Reporting Standards Page 705

by International GAAP 2019 (pdf)


  Financial instruments: Financial liabilities and equity 3565

  The treatment of the costs and gains associated with instruments is determined by their

  classification in the financial statements under IAS 32, and not by their legal form. Thus

  dividends paid on shares classified as financial liabilities (see 4.5 above) will be

  recognised as an expense in profit or loss, not as an appropriation of equity.

  The basic principle summarised above also applies to compound instruments and

  requires any payments in relation to the equity component to be recorded in equity

  and any payments in relation to the liability component to be recorded in profit or

  loss. (As discussed at 6.6.3.B above, it is not clear whether this basic principle also

  applies when the full amount of the issuance proceeds of a compound instrument is

  allocated to the liability.) A mandatorily redeemable preference share with

  dividends paid at the discretion of the entity results in the classification of a liability

  equal to the net present value of the redemption amount and an equity classification

  equal to the excess of the proceeds over the liability component (the net present

  value of the redemption amount) (see 4.5.1 above). Because the redemption

  obligation is classified as a liability, the unwinding of the discount on this component

  is recorded and classified as an interest expense. Any dividends paid, on the other

  hand, relate to the equity component and are therefore recorded as a distribution of

  profit. [IAS 32.AG37].

  Gains and losses associated with redemptions or refinancings of financial liabilities are

  recognised in profit or loss, whereas redemptions or refinancings of equity instruments

  are recognised as changes in equity. [IAS 32.36].

  Similarly, gains and losses related to changes in the carrying amount of a financial

  liability are recognised as income or expense in profit or loss, even when they relate to

  an instrument that includes a right to the residual interest in the assets of the entity in

  exchange for cash or another financial asset (see 4.6 above). However, IAS 32 notes that

  IAS 1 requires any gain or loss arising from the remeasurement of such an instrument to

  be shown separately in the statement of comprehensive income, where it is relevant in

  explaining the entity’s performance. [IAS 32.41].

  Changes in the fair value of an instrument that meets the definition of an equity

  instrument are not recognised in the financial statements. [IAS 32.36].

  IAS 32 permits dividends classified as an expense (i.e. because they relate to an

  instrument, or component of an instrument, that is legally a share but classified as a

  financial liability under IAS 32) to be presented in the statement of comprehensive

  income or separate income statement (if presented), either with interest on other

  liabilities or as a separate item. The standard notes that, in some circumstances, separate

  disclosure is desirable, because of the differences between interest and dividends with

  respect to matters such as tax deductibility. Disclosure of interest and dividends is

  required by IAS 1 (see Chapter 3) and IFRS 7 (see Chapter 50). [IAS 32.40].

  8.1

  Transaction costs of equity transactions

  An entity typically incurs various costs in issuing or acquiring its own equity instruments,

  such as registration and other regulatory fees, amounts paid to legal, accounting and

  other professional advisers, printing costs and stamp duties. The transaction costs of an

  equity transaction are accounted for as a deduction from equity, but only to the extent

  3566 Chapter 43

  they are incremental costs directly attributable to the equity transaction that otherwise

  would have been avoided. The costs of an equity transaction that is abandoned are

  recognised as an expense. [IAS 32.37].

  Although IAS 32 does not provide a definition of directly attributable incremental

  costs, IFRS 9 does define an incremental cost as ‘one that would not have been

  incurred if the entity had not acquired, issued or disposed of the financial instrument.’

  [IFRS 9 Appendix A]. IFRS 9 also gives as examples of costs which do meet this criteria:

  fees and commission paid to agents, advisors, brokers and dealers, levies by regulatory

  agencies and security exchanges, and transfer taxes and duties. [IFRS 9.B5.4.8]. Such costs

  together with other directly related costs such as underwriting and printing costs are

  usually considered to be incremental and directly attributable to the issue of equity.

  Internal administrative or holding costs e.g. costs which would have been incurred in

  any case if the equity instrument had not been issued, are not considered to be

  incremental or directly attributable.

  IAS 32 requires that only the costs of ‘issuing or acquiring’ equity are recognised in

  equity. Accordingly, it seems clear that the costs of listing shares already in issue should

  not be set off against equity, but recognised as an expense.

  The standard also requires that transaction costs that relate jointly to more than one

  transaction (for example, costs of a concurrent offering of some shares and a stock

  exchange listing of other shares) are allocated to those transactions using a basis of

  allocation that is rational and consistent with similar transactions. [IAS 32.38]. In its agenda

  decision of September 2008, the Interpretations Committee declined to provide further

  guidance on the extent of the transaction costs to be accounted for as a deduction from

  equity and how to allocate costs that relate jointly to more than one transaction,

  believing existing guidance to be adequate.

  The Interpretations Committee noted that only incremental costs directly attributable

  to issuing new equity instruments or acquiring previously issued equity instruments

  are considered to be related to an equity transaction under IAS 32, but that the terms

  ‘incremental’ and ‘directly attributable’ are used with similar but not identical

  meanings in many Standards and Interpretations, leading to diversity in practice. It

  therefore recommended that the IASB develop common definitions for both terms to

  be added to the Glossary as part of the annual improvements process.33 However, the

  IASB did not propose any such amendments in the next exposure draft published in

  August 2009.

  It may well be that, in an initial public offering (‘IPO’), for example, an entity

  simultaneously lists its existing equity and additional newly-issued equity. In that

  situation the total costs of the IPO should, in our view, be allocated between the newly

  issued shares and the existing shares on a rational basis (e.g. by reference to the ratio of

  the number of new shares to the number of total shares), with only the proportion

  relating to the issue of new shares being deducted from equity.

  Financial instruments: Financial liabilities and equity 3567

  Transaction costs that relate to the issue of a compound financial instrument are

  allocated to the liability and equity components of the instrument in proportion to the

  allocation of proceeds (see Example 43.4 at 6.2 above). [IAS 32.38].

  IAS 32 does not specifically address the treatment of transaction costs incurred to

  acquire a non-controlling interest in a subsidiary, or dispose of such an interest without />
  loss of control in the consolidated financial statements of the parent entity. IFRS 10

  indicates that ‘changes in a parent’s ownership interest in a subsidiary that do not result

  in the parent losing control of the subsidiary are equity transactions’. [IFRS 10.23].

  Accordingly, we believe that the costs of such transactions should be deducted from

  equity in accordance with the principles described above.

  IAS 32 and IFRS 10 do not specify whether such costs should be allocated to the

  parent’s equity or to the non-controlling interest, to the extent it is still reflected in

  the statement of financial position. In our view, this is a matter of choice based on

  the facts and circumstances surrounding the transaction, and any local legal

  requirements. On any subsequent disposal of the subsidiary involving loss of control,

  the transaction costs previously recognised in equity should not be reclassified from

  equity to profit or loss, since they represent transactions with owners in their

  capacity as owners rather than components of other comprehensive income.

  [IAS 1.106, 109].

  The amount of transaction costs accounted for as a deduction from equity in the period

  is required to be disclosed separately under IAS 1 (see Chapter 3 at 3.3) and IFRS 7 (see

  Chapter 50 at 7.3).

  8.2

  Tax effects of equity transactions

  As originally issued, IAS 32 required distributions to shareholders and transaction costs

  of equity instruments to be shown net of any tax benefit. Annual Improvements to

  IFRSs 2009-2011 Cycle issued in May 2012 amended IAS 32 so as to remove the

  reference to income tax benefit from IAS 32. This means that all tax effects of equity

  transactions are allocated in accordance with the general principles of IAS 12. [IAS 32.35A].

  Unfortunately, it is not entirely clear how IAS 12 requires the tax effects of certain equity

  transactions to be dealt with and different views can be taken whether tax benefits in

  respect of distributions are to be recognised in equity or profit or loss (see Chapter 29

  at 10.3.5).

  9 TREASURY

  SHARES

  Treasury shares are shares issued by an entity that are held by the entity. [IAS 32.33]. In

  consolidated financial statements, this will include shares issued by any group entity

  that are held by that entity or by any other members of the consolidated group. They

  will also include shares held by an employee benefit trust that is consolidated or

  treated as an extension of the reporting entity. Treasury shares will generally not

  include shares in a group entity held by any associates or the entity’s pension fund.

  However, IAS 1 requires disclosure of own shares held by subsidiaries or associates,

  [IAS 1.79(a)(vi)], and IAS 19 – Employee Benefits – requires disclosure of own shares

  3568 Chapter 43

  held by defined benefit plans. [IAS 19.143]. Holdings of treasury shares may arise in a

  number of ways. For example:

  • The entity holds the shares as the result of a direct transaction, such as a market

  purchase, or a buy-back of shares from shareholders as a whole, or a particular

  group of shareholders.

  • The entity is in the financial services sector with a market-making operation that

  buys and sells its own shares along with those of other listed entities in the normal

  course of business, or holds them in order to ‘hedge’ issued derivatives.

  • In consolidated financial statements:

  • the shares were purchased by another entity which subsequently became a

  subsidiary of the reporting entity, either through acquisition or changes in

  financial reporting requirements; or

  • the shares have been purchased by an entity that is a consolidated SPE of the

  reporting entity.

  The circumstances in which an entity is permitted to hold treasury shares are a matter

  for legislation in the jurisdiction concerned.

  Treasury shares do not include own shares held by an entity on behalf of others, such

  as when a financial institution holds its own equity on behalf of a client. In such cases,

  there is an agency relationship and as a result those holdings are not included in the

  entity’s statement of financial position, either as assets or as a deduction from equity.

  [IAS 32.AG36].

  If an entity reacquires its own equity instruments, IAS 32 requires those instruments to

  be deducted from equity. They are not recognised as financial assets, regardless of the

  reason for which they are reacquired. No gain or loss is recognised in profit or loss on

  the purchase, sale, issue or cancellation of an entity’s own equity instruments.

  Accordingly, any consideration paid or received in connection with treasury shares

  must be recognised directly in equity. [IAS 32.33, AG36].

  IAS 1 requires the amount of treasury shares to be disclosed separately either on the

  face of the statement of financial position or in the notes (see Chapter 3 at 3.1.6). In

  addition, IAS 32 requires an entity to make disclosure in accordance with IAS 24 –

  Related Party Disclosures – if the entity reacquires its own equity instruments from

  related parties (see Chapter 35 at 2.5). [IAS 32.34].

  As in the case of the requirements for the treatment of the equity component of a

  compound financial instrument (see 6 above), IAS 32 does not prescribe precisely what

  components of equity should be adjusted as the result of a treasury share transaction.

  This may have been to ensure that there was no conflict between, on the one hand, the

  basic requirement of IAS 32 that there should be an adjustment to equity and, on the

  other hand, the legal requirements of various jurisdictions as to exactly how that

  adjustment should be allocated within equity.

  9.1

  Transactions in own shares not at fair value

  The requirement of IAS 32 that no profits or losses should ever be recognised on

  transactions in own equity instruments differs from the approach taken in IFRS 2. If

  Financial instruments: Financial liabilities and equity 3569

  an employee share award is characterised as an equity instrument under IFRS 2 (a

  ‘share-settled’ award) and settled in cash (or other assets) at more than its fair value,

  the excess of the consideration over the fair value is recognised as an expense (see

  Chapter 30).

  It is not clear whether or not the IASB specifically considered transactions in own equity

  other than at fair value in the context of IAS 32, particularly since the relevant

  provisions of IAS 32 essentially reproduce requirements previously contained in SIC-16

  – Share Capital – Reacquired Own Equity Instruments (Treasury Shares) – which was

  implicitly addressing market purchases and sales at fair value. In other words, the

  provision can be seen merely as clarifying that, if an entity buys one of its own shares in

  the market for £10 which it later reissues in the market at £12 or £7, it has not made,

  respectively, a profit of £2 or a loss of £3.

  This is slightly different to the situation where an entity purchases an equity instrument

  for more than its fair value – i.e. if the original purchase had been for £11 when the

  market price was £10. Such a transaction could occur, for example where the entity

  wishes to rid itself of a troubl
esome shareholder or group of shareholders. In this case,

  the entity might have to offer a premium specific to the holder over and above the ‘true’

  fair value of the equity instruments concerned. However, in general, where an entity

  purchases an equity instrument for more than its fair value, this can be indicative that

  other consideration has been received by the entity. It should be noted that IFRS 2 is

  explicit that any excess of the consideration over the fair value of an equity instrument

  is recognised as an expense. [IFRS 2.28(b)].

  A transaction in which the entity issues shares (or reissues treasury shares) for cash or

  other assets with a fair value lower than the fair value of the shares would prima facie

  fall within the scope of IFRS 2, requiring the shortfall to be accounted for under IFRS 2

  (see Chapter 30 at 2.2.2.C).

  9.2

  IFRS 17 treasury share election

  An entity applying IFRS 17 – Insurance Contracts – may elect not to deduct a treasury

  share from equity, when it either:

  • operates an investment fund that provides investors with benefits determined by

  units in the fund and recognises the amounts to be paid to those investors as

  financial liabilities; or

  • issues groups of insurance contracts with direct participation features while

  holding the underlying items.

  Where an entity reacquires its own equity to hold in an investment fund or as an

  underlying item in the above arrangements, it may elect to continue to account for the

  treasury share as equity with the reacquired instrument being accounted as if it were

  a financial asset measured through profit or loss in accordance with IFRS 9. The

  election is irrevocable and made on an instrument by instrument basis. [IAS 32.33A].

  IFRS 17 is applicable for periods beginning on or after 1 January 2021 but can be early

  adopted by entities who have already adopted IFRS 9 and IFRS 15 – Revenue from

  Contracts with Customers.

  3570 Chapter 43

  10

  ‘HEDGING’ OF INSTRUMENTS CLASSIFIED AS EQUITY

  A consequence of the requirement, discussed in 4.5.2 to 4.5.6 above, to treat discretionary

  instruments with certain debt-like characteristics as equity is that the issuer will not be

 

‹ Prev